Incretin Receptor Research Explained: GLP-1, GIP and Glucagon Receptors

A primer on the three receptors behind incretin-class research peptides — GLP-1R, GIPR and GCGR — and why single, dual and tri-agonists are studied.

Key takeaways

  • Incretins (GLP-1 and GIP) amplify glucose-dependent insulin secretion; glucagon is their counter-regulatory partner.
  • All three act through class B GPCRs that signal largely via cAMP.
  • Single, dual and tri-agonists let researchers compare receptor combinations.
  • The AH series covers one, two and three receptors.

Incretin-class peptides are among the most active areas of metabolic research. They are usually described by which receptors they act on: one, two or three. This primer explains those receptors and why researchers compare single-, dual- and tri-receptor agonists.

The three receptors

ReceptorMain tissuesResearch focus
GLP-1RPancreatic beta cells, brain, gutGlucose-dependent insulin secretion, glucagon suppression, gastric emptying, appetite signaling
GIPRBeta cells, adipose tissue, CNSInsulin secretion, adipose lipid handling, interaction with GLP-1 signaling
GCGRLiver (primarily)Hepatic glucose output, lipid metabolism, energy expenditure

What incretins are

Incretins are gut hormones released after a meal that amplify insulin secretion in a glucose-dependent way. The two classic incretins are GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). Glucagon is structurally related and is the main counter-regulatory hormone to insulin. All three act through class B G-protein-coupled receptors that signal largely through cyclic AMP.

Why combine receptors?

A central question in the field is how co-activating receptors compares with activating GLP-1R alone. Adding GIPR activity brings in adipose and insulin-secretion effects; adding GCGR activity extends research into hepatic energy expenditure and lipid metabolism, with incretin signaling offsetting glucagon’s effect on glucose.

i

Because the same peptide backbone can be tuned to favor one receptor or another, comparing compounds across a single-, dual- and tri-agonist series is a common experimental design.

The After Hours Labs incretin series

See the full set in Metabolic Pathway Research, and look up the batch-matched COA for any lot.

All After Hours Labs products are sold strictly for qualified in-vitro laboratory research. They are not for human or veterinary use, and nothing in this article is medical advice or a recommendation for use in people or animals.